Stock head-to-headweekly closes, dividends reinvesteddata through Sep 2026

ABABBVvsJohnson & Johnson logoJNJ

AbbVie Inc.  /  Johnson & Johnson

Over the past five years, $10,000 in ABBV grew to $29,619, against $18,888 in JNJ. It asked more of you on the way: a −22% worst fall, against −17%.

growth of $10,000Sep 2021Sep 2026
as of Sep 2026ABBV $29,619JNJ $18,888
01At a glance

What five years of weekly data say

at a glance4 findings
  • ABBV returned +24.3% a year and JNJ +13.6% a year over the past five years, dividends reinvested.
  • JNJ was the calmer ride: 18% annual volatility, against 25%.
  • Related (correlation 0.53). They share a direction more often than not, with real room to diverge.
  • ABBV pays more income: a 2.62% yield, against 1.98% for JNJ.
02Head to head

The numbers side by side

head to head11 lines
ABBV and JNJ compared on price, size, returns, risk and cost
MetricABABBVJohnson & Johnson logoJNJ
Price$263.96$269.99
Market value$466.45B$650.65B
1-year return+22.3%+56.7% (ahead)
3-year return, a year+24.2% (ahead)+22.4%
5-year return, a year+24.3% (ahead)+13.6%
Volatility, a year25%18% (ahead)
Worst drawdown−22%−17% (ahead)
Worst week−17.3%Nov 2024−6.4% (ahead)Mar 2025
Beta0.280.23
P/E ratio74.6×31.3×
Dividend yield2.62%1.98%
marks the side ahead on lines with a direction: higher return, lower volatility, shallower fall, lower fee
03Together

Do ABBV and JNJ move together?

correlationrelated
0.53Related: they share a direction more often than not, with real room to diverge.

Correlation compares ABBV’s and JNJ’s weekly returns from Sep 2021 to Sep 2026. Two holdings near +1 fall on the same weeks, so owning both doesn’t cushion anything. Your portfolio has more than two lines, and Portfolio Terminal runs this check across every pair you hold.

Pearson correlation of weekly returns|+1 always together, 0 unrelated, −1 always opposite
04Drawdowns

How far each one fell

drawdownsbelow each one’s previous high
as of Sep 2026ABBV −0.4%JNJ −1.9%

ABBV

−22%

From its Apr 2022 high to Sep 2022. Back at that high by Jan 2024.

JNJ

−17%

From its Jan 2023 high to Oct 2023. Back at that high by Jul 2025.

Worst peak-to-trough fall on weekly closes · dividends reinvested

05Questions

ABBV vs JNJ: what people ask

questions5 answered

Is ABBV better than JNJ?

Over the past five years, ABBV delivered the higher return: +24.3% a year against +13.6% for JNJ, dividends reinvested. It also fell further at its worst (−22% against −17%), so the extra return came with a rougher ride. Which is better depends on the job it does in your portfolio, and past returns don’t predict future ones.

What is the difference between ABBV and JNJ?

ABBV is AbbVie Inc. (Drug Manufacturers—General), worth $466.45B. JNJ is Johnson & Johnson (Drug Manufacturers—General), worth $650.65B.

Should I own both ABBV and JNJ?

Their weekly returns had a correlation of 0.53 over the past five years. They share a direction more often than not, with real room to diverge. Whether that suits you depends on everything else you hold, which is the check Portfolio Terminal runs across a whole portfolio.

Which is riskier, ABBV or JNJ?

ABBV swung more: 25% annual volatility against 18% for JNJ. At their worst, ABBV fell 22% and JNJ 17% from a previous high. Against the broad market, their betas are 0.28 and 0.23.

Which pays a higher dividend, ABBV or JNJ?

ABBV currently yields 2.62%, against 1.98% for JNJ. Yields move with price, so a higher yield can also mean a falling price.

Returns use weekly closes adjusted for dividends and splits, from Sep 2021 to Sep 2026. Quotes, fees and holdings come from public market data and refresh hourly. This page describes what happened; it is not investment advice, and past performance doesn’t predict future returns.